Accessibility Menu

Semnur Pharmaceuticals(OTC) SMNR

Market Cap$126.62MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2022)-94%
5 YearN/A
1 Year-95%
1 Month-35%
$0.55
+0.00%
+0.00Today
Semnur Pharmaceuticals last closing stock price
MetricPriceDate
Last closeUSD 0.552026-08-31
Semnur Pharmaceuticals stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-11.29%USD 0.622026-08-24
1 month-35.29%USD 0.852026-07-31
3 month-89%USD 5.002026-06-02
Year to date-96.33%USD 15.002025-12-31
1 year-95.44%USD 12.052025-08-28
3 year-94.94%USD 10.872023-09-01
Since inception-94.48%USD 9.962022-06-07

Semnur Pharmaceuticals Financials at a Glance

Market Cap

$126.62MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$167.67

EPS (TTM)

-$0.82

P/E Ratio

-0.67

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.55

Volume

3,878

Open

$0.55

Previous Close

$0.55

Daily Range

$0.55 - $0.60

52-Week Range

$0.25 - $23.00

Estimated Earnings Date

N/A

SMNR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Semnur Pharmaceuticals

Semnur Pharmaceuticals, Inc. engages in developing and commercializing innovative non-opioid pain management products for the treatment of acute and chronic pain. It offers the product, SP-102, a non-opioid novel injectable corticosteroid gel formulation for patients with moderate to severe lumbosacral radicular pain. The company was founded in 2013 and is headquartered in Palo Alto, CA.

Industry

Pharmaceuticals

Sector

Health Care

Employees

5

CEO

Henry H. Ji, PhD

Website

www.semnurpharma.com

SMNR Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

-9.04%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-1.49%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

$126.62MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

230.21M

Volume

3.88K

Avg. Volume

28.90K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Semnur Pharmaceuticals Performance Analysis

Semnur Pharmaceuticals annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
20242024-12-31USD 0N/A
20252025-12-31USD 0N/A
Semnur Pharmaceuticals annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.04N/A
20232023-12-31USD 0.06N/A
20242024-12-31USD -0.02N/A
20252025-12-31USD -0.783247.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

N/A

N/A

Market Cap

$126.62MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$23.02

+1.5%

Employees

5

+2.5%

Net Income

-$4.35

+11.3%

EBITDA

-$4.22

+11.3%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$23.09

+672.7%

Total Debt

$23.05

+7.7%

Accounts Receivable

N/A

N/A

Inventory

$0.00

N/A

Long Term Debt

$20.94

N/A

Short Term Debt

$2.11

+0.7%

Return on Assets

-13384.76%

+2414.2%

Return on Invested Capital

437.20%

+101.2%

Free Cash Flow

-$2.14

+30.8%

Operating Cash Flow

-$2.14

+30.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,634.27-0.01%
^DJIDJI
$52,797.46-0.01%
^IXICNASDAQ
$26,099.39-0.01%
BTCBitcoin
$77,103.00-0.02%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$14.06+0.06%
NVDANvidia
$217.44-0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.33-0.06%
INTCIntel
$88.97-0.01%

Questions About SMNR

What is the current price of Semnur Pharmaceuticals?

Semnur Pharmaceuticals is trading at $0.55 per share.

What is the 52-week range for Semnur Pharmaceuticals?

Over the past 52 weeks, Semnur Pharmaceuticals has traded between $0.25 and $23.00.

How much debt does Semnur Pharmaceuticals have?

As of the most recent reporting period, Semnur Pharmaceuticals reported total debt of $23.05M.

How much cash does Semnur Pharmaceuticals have on hand?

Semnur Pharmaceuticals reported $39.00K in cash and cash equivalents in its most recent financial results.

What is Semnur Pharmaceuticals’s dividend yield?

Semnur Pharmaceuticals does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services